Revolution of Healthcar. Bring Healthcare with Blockchain Technology

Hello, Welcome back to me. I will tell you about this ICO. So, please close attention.

Healthcare systems are often required to make the difficult decision of whether to reimburse costly pharmacological therapies and provide access for patients while taking into account their limited resources. Innovative pricing approaches have the ability to overcome the challenges faced by healthcare systems when assessing the funding of new drugs, to enable the implementation of ‘flexible’ pricing schemes to assess the price of treatment in relation to the benefits it delivers. Unfortunately, healthcare systems around the world lack the relevant infrastructure to track and implement innovative pricing models such as value-based pricing agreements, and so are reluctant to adopt such innovative policies. This results in novel pharmacological therapies being denied to patients who are most in need, an opportunity missed decreasing the long-term economic and disease burden on health systems, and a barrier to reimbursement for manufacturers.


Bring Solution for Healthcare
Digipharm brings together industry expertise, a mature concept, and revolutionary blockchain technology to facilitate the transformation of healthcare to a value-based approach.

Spiraling healthcare costs combined with resource constraints have resulted in an unremitting burden on health systems. Trade-offs need to be made, patients are at risk of being denied innovative treatments and there remain barriers to reimbursement for manufacturers.

Digipharm bypasses infrastructural limitations to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of unprecedented evidence platforms and the ability to reward patients for contributing their data.

Reimburse
Reimburse will eliminate the infrastructural barriers and automate the implementation of value-based pricing agreements, no matter how complex, on a fully independent global platform; encouraging personalized reimbursement of health technology on a ‘fee for performance’ basis for the mutual benefit of patients, payers and manufacturers.

• Accelerates access to high-cost therapy
• Incentivises innovation
• Drastically reduces administrative costs

Insights
Insights are the first ever ‘live’ real world evidence repository and allows the utilization of real-world evidence (RWE) as soon as it becomes available. The availability of ‘live’ RWE will provide stakeholders with real-time intelligence with which they can inform decision making and product development across the medicinal lifecycle.

• Incentives for patients to contribute data
• Significant cost savings compared to conventional RWE sources
• Single platform for global evidence

DPH Token

DPH Supply: 100,000,000 Fixed (ERC-20)

Ticker code: DPH

Decimal Places: 18

Token Price 1.00 USD

Token Sale

Pre - Sale: 15,000,000 DPH

Base Price: $1.00 USD

Pre - Sale Discount: 35%

Pre - Sale Length: 4 Weeks

Main Sale: 50,000,000 DPH

Week 1: 25% (Capped at 25 million tokens)

Week 2: 15% (Capped at 15 million tokens)

Week 3: 10% (Capped at 10 million tokens)

Week 4: 1.00 USD

For More Information About This ICO :

Website: https://www.digipharm.ch/

Whitepaper: https://digipharm.ch/docs/DigipharmWP.pdf

Telegram: https://t.me/joinchat/ExOHxk-TuOplQDbBWXaLaQ

Facebook: https://www.facebook.com/digipharmteam/

Twitter: https://twitter.com/DigipharmTeam

Profile Bitcointalk: https://bitcointalk.org/index.php?action=profile;u=1011815

ETH : 0x05cF614Bb13F01bEb95f56C2891A4c22DaF78244